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AbstractThis study concerned on an exploration regarding 
economic evaluation of health care-related researches in 
Southeast Asian countries from the published articles. I ts aim 
was to describe the situation of economic evaluation of health 
care-related researches conducted in Southeast Asian countries 
from the published articles and explores a brief of the 
methodology applied in the studies. A literature search was 
conducted in September 2012 using the Medline electronic 
database with the PubMed interface. A combination of MeSH 
terms of 
		 

employed. L imitation was set for articles published at last 10 
years in English language. Out of 306 records, 83 eligible 
articles were retr ieved and reviewed. I t was found that the 
studies had been conducted in eight of eleven countries in the 
region and one study conducted across the region. Thailand 
had the greatest number of publications (34), followed by 
Singapore (17). The number of articles regarding economic 
evaluation of health care-related in Southeast Asian countries 
increased over the time. The capacity of local researchers both 
in number and the role as first/cor respondence author was 
more than of researchers f rom outside the country. Most of the 
authors were affiliated with the university and hospital. Most 
of studies that revealed the funding source got the funding 
support f rom international sources. The economic evaluation 
methods mostly used were C O I and C A (65%), while there was 
also a consideration number of the use of C E A (13%) and 
C U A (17%) in the studies. F rom the studies reviewed, 
infectious diseases and chronic diseases were the most issues on 
economic evaluation of health care-related in Southeast Asian 
countries. The review give conclusion that such economic 
information is gaining importance in policy decision making 
for the particular setting in Southeast Asia country . A 
consideration number of studies on economic evaluation of 
health care-related in Southeast Asian countries gives 
possibility of using or adopting the economic evidences  as well 
as the methodologies to be applied in other settings across the 
region. 
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I.INTRODUCTION 
 Economic evaluation is the comparison of two or 
more alternative courses of action (interventions) in terms of 
both their costs and consequences. There are several types 
of economic evaluation distinguished by the experts in 
economics with the difference on how the consequences are 
measured. The types of economic evaluation include cost-
minimization analysis, cost-benefit analysis, cost-
effectiveness analysis, and cost-utility analysis [1]. Those 
types are called full-economic evaluation method. Another 
type, which is cost of illness or cost of treatment, is not a 
true economic evaluation, as it does not compare the costs 
and outcomes of interventions, therefore it is called partial-
economic evaluation method [2]. The administrators should 
choose the method of economic evaluation to be used in 
their studies based on several considerations such as the 
objective of the study, the characteristics of interventions, 
and the possible outcomes measurement. 
Economic evaluation is a tool to help priority 
setting of such programs including health interventions.  
Given the resource scarcity of the health sectors particularly 
in the low-income countries, the government of those 
countries should concentrate on more effectively utilizing 
the available resources. Economic evaluation guides policy 
makers wishing to maximize the benefits produced by the 
scarce resources available to them [3]. Each method of 
economic evaluation could provide the specific information 
presenting the best possible choice of interventions that 
suitable for their problem and setting. 
 Economic evaluation has the potential uses include 
the development of public reimbursement lists, price 
negotiation, the development of clinical practice guidelines, 
and communicating with prescribers. Unfortunately there 
are barriers to use economic evaluation, namely barriers 
relating to the production of economic evaluation data and 
decision context-related barriers. In the western/developed 
countries such as Canada, the UK, and The Netherland; 
economic evaluation has been formally accepted for use in 
policy decision-making. While in Asia, only a few countries 
currently adopt economic evaluation as a formal tool for 
informing health policy decisions. However, there has been 
impetus to justify resource allocation decisions in the health 
sector among the Asian countries [4-5]. 
 This study concerned on an exploration regarding 
economic evaluation of health care-related researches in 
Southeast Asian countries from the published articles. Its 
aim was to describe the situation of economic evaluation of 
healthcare-related researches conducted in Southeast Asian 
countries from the published articles and explore a brief of 
the methodologies applied in the studies. 
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II.METHODS 
A. Searching Method 
 A literature search was conducted in September 
2012 using the Medline electronic database with the 
PubMed interface. A combination of MeSH terms of #


$ #
 
$
#


$
employed. 
Limitation was set for articles published at last 10 years in 
English language. Inclusion criteria were the study of 
economic evaluation related to health care conducted in the 
settings of Southeast Asian countries or Southeast Asian 
region; either abstracts or full articles that can be accessed. 
While the searching excluded the review articles. 
B. Data Extraction 
 The following information were obtained from 
each study included in the review: type of document 
(abstract, full article); setting of study (country or region); 
year of publication; health care-related category; capacity of 
local researcher on the studies (articles written by local 
authors or written by outside authors or written in 
collaboration of both local and outside authors, local authors 
as the first or correspondence author); institution on which 
the author is affiliated; economic evaluation method (cost 
analysis, cost of illness, cost-minimization analysis, cost-
benefit analysis, cost-effectiveness analysis, cost-utility 
analysis, and budget impact analysis); design of the study 
based on the data collection method (retrospective, cross 
sectional, prospective, modeling); and availability of 
funding for the study as well as the source of funding.  
 
III. RESULTS 
Searching result 
The literature search found 306 records, 223 of 
which did not meet the inclusion criteria and were therefore 
excluded. Eighty-three eligible articles were retrieved. Of 
the 83 articles retrieved, 60 articles (72%) were full texts, 
while 23 articles were abstracts available only. Finally, the 
83 articles retrieved were reviewed. 
 
Setting of the study 
 It was found that the studies had been conducted in 
eight of eleven countries in the region and one study was 
conducted across the region. Thailand had the greatest 
number of publications (34); followed by Singapore (17); 
Indonesia, Malaysia, and Vietnam (8); Cambodia (4); the 
Philippines (2); and Laos (1). 
 
Number of publications over the time 
 The distribution of the articles over the time was 
shown on Figure 1. There is a fluctuation of the number of 
articles from the year 2003 to the year 2012, however the 
number of articles tended to increase over the time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1. Distribution of the articles over the time 
 
Capacity of local researcher 
 Among the articles, 38 articles (46%) were written 
by local researchers, 5 articles (6%) by outside researchers, 
and 40 articles (48%) in collaboration of both. Fifty-eight 
articles (70%) mentioned the name of a local researcher as 
the first or corresponding author. The total number of local 
authors involved in the studies is 279 authors, more than 
that of outside authors, which are 133 authors. The data 
gave conclusion that most of the studies were written by 
local researchers as well as the local authors had more 
participation in the articles as their number was bigger and 
they were mentioned as the first or correspondence author 
more frequently than the outside authors. 
 
Affiliation of the author 
 The highest number of the article was written by 
the authors affiliated with the university, followed by the 
articles written by the authors affiliated with the hospital. 
Among all the articles, 24 articles were written solely by the 
authors affiliated with the university, while 42 articles were 
jointly written by the authors affiliated with the university 
and other institution such as hospital, ministry of health, 
research center, insurance company, and pharmaceutical 
company. Third ten articles were written by authors tha 
affiliated with the hospital and 22 articles were written in 
collaboration of authors affiliated with hospital and other 
institutions. Nine ten articles were written by the authors 
affiliated with the government office of ministry of health in 
collaboration with authors from other institution. Only one 
article is written solely by the authors from the research 
center, while 18 articles were jointly written by the authors 
from the research center and the other institution. Only 2 
articles were written by the authors from the pharmaceutical 
company. 
 
Research funding sources 
 Among the articles, 51 articles revealed their 
funding sources, while 32 articles did not mention about the 
funding source in the article. Of the 51 articles that revealed 
their funding sources, most of them were supported by 
international non-profit organizations such as the World 
Health Organization (WHO), World bank/Programme of 
Advancement Through Health and Education (PATH), 
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European commission, and many others. It was accounted 
for 21 studies were solely supported by international non-
profit organizations. Four studies were solely supported by 
domestic public funds, while 3 studies were jointly 
supported by both domestic public funds and international 
non-profit organizations. Eight studies were funded solely 
by the university as well as 2 studies were solely funded by 
the hospital. The pharmaceutical companies supported 7 
studies in this review, while domestic non-profit 
organizations supported 2 studies in this review. Finally, 4 
studies clearly mentioned that they did not receive any 
funding support from other sources. 
 
Method of economic evaluation 
 Figure 2 shows the distribution of economic 
evaluation methods applied in the studies. Generally, 
economists distinguish four types of economic evaluation 
methods, which therefore are called full-economic 
evaluation method. They are cost-minimization analysis 
(CMA), cost-benefit analysis (CBA), cost-effectiveness 
analysis (CEA), and cost-utility analysis (CUA) [1]. The 
others mention about cost of illness (COI) or cost of 
treatment as well as cost analysis as part of economic 
evaluation method which is called partial-economic 
evaluation method, however this method is not a true true 
economic evaluation as it does not compare the costs and 
outcomes of interventions [2]. Another term, budget impact 
analysis (BIA) is an essential part of a comprehensive 
economic assessment of a health-care technology. The BIA 
is purposed to estimate the financial consequences of such 
program/intervention within a specific health-care setting 
[6]. 
 Among the type of economic evaluation applied in 
the studies reviewed, partial-economic evaluation method 
(COI and CA) has become the predominant method of 
economic evaluation which accounted for 65%, while 
among the full-economic evaluation method solely, CUA 
and CEA have been used widely which accounted for 17% 
and 13% respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Distribution of economic evaluation methods applied in the 
studies 
Design of study 
 The design of economic evaluation studies in the 
healthcare field can employ among three essential types of 
methodologies, which are retrospective, prospective, and 
predictive. Retrospective studies based on a design that is 
observational and using administrative registries or 
reviewing clinical histories. Prospective studies combine 
prospectively collected clinical trial data with resource data 
collected retrospectively. While predictive studies can 
employ data from epidemiological studies, meta-analysis, 
community trials and expert opinions to create the models 
that allow projections to be made on the consequences of 
adopting certain health measures [7]. 
 Among the studies reviewed, 23 studies used 
retrospective data, 19 studies used prospective data, 17 
studies used cross sectional data, and 3 studies used both 
retrospective and cross sectional data. Finally, 21 studies 
employed modeling technique to conduct economic 
evaluations. 
 
Distribution of studies by disease/intervention category 
 Figure 3 shows the distribution of published 
economic evaluations that were reviewed by the 
disease/intervention category. The disease categories were 
grouped referring to the International Classification of 
Diseases version 10 (ICD-10) with modification [8]. The 
disease categories covered by the published economic 
evaluations reviewed show a high share in certain categories 
such as infectious diseases and chronic diseases, and a low 
share in other categories. 
 Most of the studies dealt with infectious diseases 
(19 articles) and chronic diseases (18 articles). Infectious 
diseases found in the articles reviewed included respiratory 
tract infections (pneumonia, tuberculosis, chronic 
obstructive pulmonary disease (COPD)); gastrointestinal 
tract infections (bacterial diarrhea, rotavirus 
diarrhea/gastroenteritis, Helicobacter pilory infection); 
meningitis; sepsis; dengue fever; herpes-zoster infection; 
and communicable illnesses. Chronic diseases in the articles 
reviewed consisted of diabetes; asthma; renal diseases; 
cardiovascular diseases; thalassemia; rheumatoid and 
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Figure 3. Distribution of published economic evaluations by  
disease/intervention category 
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 Another infectious disease, HIV/AIDS, had a 
considerable number (7 studies) being an issue on economic 
evaluation in this review. While the rest disease 
categories/interventions that were cancer, eye problems, 
hospital services, injuries, mental disorders, and vaccination 
had the comparable number of studies in this review (4-6 
studies each category). The others, explicit category 
mentioned in the group, included perinatal care, tobacco 
control program, overactive bladder, dental service, and 
medical devices usage that accounted for 9 studies. 
 
IV. DISCUSSION 
 Finding from the review shows that the number of 
articles regarding economic evaluation of health care-related 
in Southeast Asian countries increased over the time. It 
shows that there is a good progress in economic evaluation 
studies in Southeast Asian countries as one consideration in 
health care program policy. The capacity of local 
researchers both in number and the role as 
first/correspondence author are more than researchers from 
outside. Local researchers conducted most of the studies. It 
can be assumed that such economic information is gaining 
importance in policy decision making for the particular 
setting.  
 It is also beneficial to review the economic 
evaluation conducted in other setting. The methodology 
employed in the studies and the results of the studies both 
can be useful to be adopted in other setting [1]. However, it 
is impossible to directly 
  $ approaches 
using economic evaluation for priority setting because of 
several constraints specifically related to the context of each 
setting [4]. The users should consider many factors related 
to the characteristics of their own setting if they want to use 
the economic evidence from other settings as well as 
employ the methodology applied in other settings. 
 The trend of progress of economic evaluation 
studies in each country in Southeast Asia was different. It 
might be affected by several factors such as the differences 
of health system, support from the local government and 
international organization or other parties, and the activities 
of academic researchers.  
 For example, Thailand has done the health care 
system reform by implementing the Universal Coverage 
(UC) policy as the health insurance system which was 
started in April 2001 as a pilot project in 6 provinces and 
implemented nationwide in April 2002 [9]. The UC offers a 
package of healthcare interventions to patients at public 
facilities, which need economic evaluations information as 
one consideration to formulate the benefit package [5]. This 
factor influenced the high number of economic evaluation 
studies conducted in Thailand.   
 Another factor is the beginning and development of 
health technology assessment (HTA) in Asia. The main 
purpose of HTA is to inform technology-related policy 
making in health care, where policymaking is used in the 
broad sense to include decisions made in the level of 
institutional, regional, national, and international [10]. The 
HTA employ economic evaluation studies as one 
consideration in policy decision-making. Some countries in 
Southeast Asia have established the HTA to be used in the 
healthcare program implementation; such as Thailand, 
Singapore, Malaysia, and the Philippines [11]. 
 Most of the authors were affiliated with the 
university and hospital. It shows the strong influence of 
academic researchers to the progress of economic evaluation 
studies, while the researchers from the hospital tend to 
conduct the studies for their own setting. A consideration 
number of studies involved the researchers from the 
government (ministry of health), which shows the gaining 
important of economic evaluation information to be used in 
policy making of the healthcare. Very few studies were 
conducted by the pharmaceutical companies. In particular 
country such as Australia, it is required for pharmaceutical 

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committee if they want their products to be included in the 
benefit package, which is subsidized by government. In the 
future, this regulation is not impossible to be applied in 
Southeast Asian countries once they do the healthcare 
system reform. 
 Most of studies that revealed the funding sources 
got the funding support from international sources. It 
indicates the lack of domestic resource allocation on 
economic evaluation studies. More over, the studies were 
conducted only as a part of international research project, 
not as an inisiation program from the needs of local setting. 
However, the positive effects came from the good 
networking with international collaboration. 
 The economic evaluation methods mostly used 
were COI and CA, which are the partial-economic 
evaluation. These methods cannot give direct information of 
economic evidence to guide the policy makers. However, 
the results of these studies could provide the information as 
input to conduct the further full-economic evaluation and 
give the figure of economic burden of such disease or unit 
cost of such healthcare program/intervention [12]. There 
was also a consideration number of the use of CEA and 
CUA in the studies. CBA and CUA can be used to assess 
allocative efficiency. CBA has the widest scope of the types 
of analysis because the monetization of outcomes enables 
inter-sectoral comparisons. CEA estimates the incremental 
cost and effect of a new program/intervention compared 
with current practice and provides an estimate of the 
efficiency or value of the new program/intervention. While 
CUA is identical with CEA which differ in the expression of  
the outcome in a combined measure of morbidity and 
mortality in terms of quality-adjusted life years (QALYs) or 
disability-adjusted life years (DALYs), therefore CUA is the 
preferred option in conducting economic evaluation of 
healthcare-related [13]. 
 It is important to conduct economic evaluations 
focusing on interventions to improve decision-making, 
although not have to be based purely on disease burden. The 
studies should provide the information for guiding the 
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decision-making on the major health problems in the setting 
and therefore potentially have a large impact on population 
health [4]. From the studies reviewed, infectious diseases 
and chronic diseases were the most issues on economic 
evaluation of health care-related in Southeast Asian 
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	$
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risks to health, infectious diseases were still the most major 
cause of disease burden in the developing countries as most 
of Southeast Asian countries [14]. Therefore, in the national 
level economic evaluations on infectious diseases including 
HIV/AIDS as well as vaccination should be the main 
priority instead of other issues.  
 It is necessary to point out the limitation of this 
review. Firstly, the method used in this study should find the 
more number of published economic evaluations of health 
care-related in Southeast Asian countries if the method was 
expanded to use more database sources and keywords. The 
review will give more real figure of economic evaluation 
researches conducted in Southeast Asian countries if it also 
consider the other data sources; such as national or regional 
published database, unpublished database as well as of the 
grey literature. Secondly, this study only reviewed small 
parts of the articles of published economic evaluation on 
health care-related in Southeast Asian countries, even 
without filtered the quality of the articles. However, this 
review could give a brief figure about the economic 
evaluation researches conducted in Southeast Asian 
countries.  
 
V. CONCLUSIONS 
 A review was conducted of publications focusing 
on the economic evaluation of health care-related in 
Southeast Asian countries. Local researchers conducted 
most of the studies as well as the local authors had much 
participation in conducting the studies. It can be assumed 
that such economic information is gaining importance in 
policy decision making for the particular setting in 
Southeast Asia countries. A consideration number of studies 
on economic evaluation of health care-related in Southeast 
Asian countries gives possibility of using or adopting the 
economic evidences  as well as the methodologies to be 
applied in other settings across the region. 
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